Back to top

Image: Shutterstock

Top Ranked Momentum Stocks to Buy for May 3rd

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 3rd:

The Cheesecake Factory Incorporated (CAKE - Free Report) : This restaurant company and distributor of cheesecakes has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 81.6% over the last 60 days.

 

The Cheesecake Factory’s shares gained 6.9% over the last one month compared to S&P 500’s rise of 2.8%. The company possesses a Momentum Score of A.

 

Penske Automotive Group, Inc. (PAG - Free Report) : This diversified transportation services company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days.

 

Penske Automotive’s shares gained 6.8% over the last one month. The company possesses a Momentum Score of B.

 

BankUnited, Inc. (BKU - Free Report) : This bank holding company for BankUnited has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.3% over the last 60 days.

 

BankUnited, Inc. Price and Consensus

BankUnited, Inc. Price and Consensus

BankUnited, Inc. price-consensus-chart | BankUnited, Inc. Quote

 

BankUnited’s shares gained 5.6% over the last one month. The company possesses a Momentum Score of B.

 

Selective Insurance Group, Inc. (SIGI - Free Report) : This regional insurance holding company carries a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.2% over the last 60 days.

 

Selective Insurance’s shares gained 3.1% over the last one month. The company possesses a Momentum Score of A.

 

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>